Side effects seen in people who have taken Covaxin, one out of every three people is suffering from these diseases

Recently, Oxford-AstraZeneca, the company that manufactures Covishield, has admitted that its corona vaccine can cause many side effects in people, including blood clots (Covishield Side Effects). In such a situation, now a surprising research has come to light regarding Covaxin. Till now only Covishield was under question. But now research on Covaxin has also raised many questions on Covaxin Side Effects. In such a situation, if you have also taken Covaxin, then this news is for you.

Side effects seen in people taking Covaxin
After questions raised on the side effects of Corona vaccine Covishield, now Covaxin is also under suspicion. Researchers at Banaras Hindu University have published a research regarding Covaxin. The results of which have raised many questions on Covaxin after Covishield. BHU published the report of its study in the Springer Link journal. According to which, it is being said that some side effects are being seen in about one third of the people who get Covaxin.

These side effects were seen (Covaxin Side Effects)
One thousand 24 people were included in this study of BHU. These people included 635 teenagers and 291 youth. Whose follow-up and checkup was done for one year after vaccination. In such a situation, problems like viral upper respiratory tract infection have been seen in about 48% of the people involved in the research, i.e. 304 teenagers. Along with this, nerve related problems were seen in 407% people. So, pain in nerves and joints due to the vaccine was seen in 5.8% of the youth.

Covaxin has greater effect in women
According to the report, the effect of Bharat Biotech’s Covaxin is more visible in women. Let us tell you that about 4.6% women are facing problems related to menstruation. Eye related problems have been reported in 2.7 percent women. Along with this, hypothyroidism has been found in 0.6 percent women. At the same time, serious side effects have also been seen in one percent of people.